Sclerostin antibodies in osteoporosis: latest evidence and therapeutic potential.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2017, v. 9, n. 10, p. 263, doi. 10.1177/1759720X17726744
- By:
- Publication type:
- Article
Works matching IS 1759720X AND DT 2017 AND VI 9 AND IP 10
Results: 3
1
2
Rituximab biosimilar in rheumatoid arthritis: an enhanced-evidence assessment to evaluate equivalence with the originator based on network meta-analysis.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2017, v. 9, n. 10, p. 271, doi. 10.1177/1759720X17721151
- By:
- Publication type:
- Article
3
Sustained remission in rheumatoid arthritis: latest evidence and clinical considerations.
- Published in:
- Therapeutic Advances in Musculoskeletal Disease, 2017, v. 9, n. 10, p. 249, doi. 10.1177/1759720X17720366
- By:
- Publication type:
- Article